Table 2 Peri-operative outcomes
Total | Low risk (0–3) | Intermediate risk (4–7) | High risk (8–10) | P-value | |
|---|---|---|---|---|---|
Ischemia time, minutes | 24 (11) | 22 (10) | 27 (13) | 28 (13) | < 0.001 |
Operative time, minutes | 227 (97) | 210 (109) | 234 (80.5) | 265 (67) | 0.003 |
EBL, mL | 150 (250) | 100 (250) | 150 (212.5) | 200 (175) | 0.59 |
Complications | 0.03 | ||||
minor, Clavien-Dindo grade 2 or less | 49 (23.7) | 28 (23.3) | 18 (24.3) | 3 (23) | |
major, Clavien-Dindo grade 3 or more | 8 (3.9) | 7 (5.8) | 0 (0) | 1 (7.7) | |
Length of stay, days | 8 (2) | 7 (3) | 8 (2) | 8 (2.5) | 0.02 |
ACE-3rd day | 11 (21) | 8.5 (21) | 13.5 (24.25) | 20 (30) | 0.008 |
PCE-3rd day | 14 (23) | 10.5 (23) | 17.5 (26.75) | 22 (30) | 0.005 |
ACE-30th day | 8 (15) | 4 (16) | 9.5 (14) | 17 (11) | 0.007 |
PCE-30th day | 10 (17) | 6.5 (18) | 11.5 (13.5) | 16 (12.5) | 0.018 |
ACE-1st year | 12 (18) | 8.5 (16) | 14.5 (17.25) | 29 (18.5) | < 0.001 |
PCE-1st year | 14.9 (18.2) | 11.8 (18.8) | 17 (16.5) | 34 (16.8) | < 0.001 |
CKD upstaging | 30 (14.5) | 16 (13.3) | 10 (13.5) | 4 (30.8) | 0.22 |
Pathological features | 0.45 | ||||
clear cell RCC | 95 (45.9) | 52 (43.3) | 37 (50) | 6 (46.2) | |
papillary RCC | 18 (8.7) | 10 (8.3) | 7 (9.5) | 1 (7.7) | |
chromophobe RCC | 17 (8.2) | 7 (5.8) | 9 (12.2) | 1 (7.7) | |
others | 7 (3.4) | 3 (2.5) | 3 (4.1) | 1 (7.7) | |
oncocytoma | 8 (3.9) | 3 (2.5) | 4 (5.4) | 1 (7.7) | |
angiomyolipoma | 62 (30) | 45 (37.5) | 14 (18.9) | 3 (23.1) | |
Positive surgical margin | 8 (3.9) | 6 (5) | 1 (1.4) | 1 (7.7) | 0.24 |
Achievement of trifecta | 112 (54.1) | 73 (60.8) | 35 (47.3) | 3 (23.1) | 0.02 |
Achievement of pentafecta | 51 (24.6) | 43 (35.8) | 8 (10.8) | 0 (0) | 0.01 |